BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30830309)

  • 21. The relationship between advanced oxidation protein products (AOPP) and biochemical and histopathological findings in patients with nonalcoholic steatohepatitis.
    Ozenirler S; Erkan G; Konca Degertekin C; Ercin U; Cengiz M; Bilgihan A; Yilmaz G; Akyol G
    J Dig Dis; 2014 Mar; 15(3):131-6. PubMed ID: 24528633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients.
    Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B
    Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced oxidation protein products in nondiabetic end stage renal disease patients on maintenance haemodialysis.
    Colombo G; Reggiani F; Astori E; Altomare A; Finazzi S; Garavaglia ML; Angelini C; Milzani A; Badalamenti S; Dalle-Donne I
    Free Radic Res; 2019 Dec; 53(11-12):1114-1124. PubMed ID: 31755327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease.
    Miletić J; Drakulić D; Pejić S; Petković M; Ilić TV; Miljković M; Stefanović A; Prostran M; Stojanov M
    Int J Neurosci; 2018 Jul; 128(7):600-607. PubMed ID: 29148896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidative stress markers in neonatal respiratory distress syndrome: advanced oxidation protein products and 8-hydroxy-2-deoxyguanosine in relation to disease severity.
    Elkabany ZA; El-Farrash RA; Shinkar DM; Ismail EA; Nada AS; Farag AS; Elsayed MA; Salama DH; Macken EL; Gaballah SA
    Pediatr Res; 2020 Jan; 87(1):74-80. PubMed ID: 31216566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced oxidation protein product level in children with chronic otitis media with effusion.
    Balıkcı HH; Karakaş M; Gürdal MM; Ozkul MH; Bayram O; Bayram AA; Yigit S
    Int J Pediatr Otorhinolaryngol; 2014 Mar; 78(3):551-3. PubMed ID: 24491806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced oxidation protein products, ferrous oxidation in xylenol orange, and malondialdehyde levels in thyroid cancer.
    Kosova F; Cetin B; Akinci M; Aslan S; Ari Z; Sepici A; Altan N; çetin A
    Ann Surg Oncol; 2007 Sep; 14(9):2616-20. PubMed ID: 17564752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In major affective disorders, early life trauma predict increased nitro-oxidative stress, lipid peroxidation and protein oxidation and recurrence of major affective disorders, suicidal behaviors and a lowered quality of life.
    Moraes JB; Maes M; Roomruangwong C; Bonifacio KL; Barbosa DS; Vargas HO; Anderson G; Kubera M; Carvalho AF; Nunes SOV
    Metab Brain Dis; 2018 Aug; 33(4):1081-1096. PubMed ID: 29542039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carnosine Treatment Diminished Oxidative Stress and Glycation Products in Serum and Tissues of D-Galactose-Treated Rats.
    Aydin F; Kalaz EB; Kucukgergin C; Coban J; Dogru-Abbasoglu S; Uysal M
    Curr Aging Sci; 2018; 11(1):10-15. PubMed ID: 28676006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.
    Altunoglu E; Guntas G; Erdenen F; Akkaya E; Topac I; Irmak H; Derici H; Yavuzer H; Gelisgen R; Uzun H
    Geriatr Gerontol Int; 2015 Jul; 15(7):872-80. PubMed ID: 25345484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores.
    Najafizadeh SR; Amiri K; Moghaddassi M; Khanmohammadi S; Mirmiranpour H; Nakhjavani M
    Clin Rheumatol; 2021 Oct; 40(10):4019-4026. PubMed ID: 34050440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of prolidase activity and oxidative stress in patients with oral lichen planus and oral lichenoid contact reactions.
    Batu Ş; Ofluoğlu D; Ergun S; Warnakulasuriya S; Uslu E; Güven Y; Tanyeri H
    J Oral Pathol Med; 2016 Apr; 45(4):281-8. PubMed ID: 26661727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased oxidant profile and increased antioxidant capacity in naturally postmenopausal women.
    Victorino VJ; Panis C; Campos FC; Cayres RC; Colado-Simão AN; Oliveira SR; Herrera AC; Cecchini AL; Cecchini R
    Age (Dordr); 2013 Aug; 35(4):1411-21. PubMed ID: 22645022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma.
    Barut O; Vural P; Şirin Ş; Aydin S; Dizdar Y
    Acta Odontol Scand; 2012 Jul; 70(4):303-8. PubMed ID: 21815836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
    Ljubisavljevic S; Stojanovic I; Cvetkovic T; Vojinovic S; Stojanov D; Stojanovic D; Stefanovic N; Pavlovic D
    J Neurol Sci; 2014 Feb; 337(1-2):8-13. PubMed ID: 24269090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of total oxidant status, total antioxidant status, and malondialdehyde and catalase levels with psoriasis: a systematic review and meta-analysis.
    Zhang Y; Li Z; Ma Y; Mu Z
    Clin Rheumatol; 2019 Oct; 38(10):2659-2671. PubMed ID: 31321579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advanced Oxidation Protein Products as a Novel Marker of Oxidative Stress in Postmenopausal Osteoporosis.
    Wu Q; Zhong ZM; Pan Y; Zeng JH; Zheng S; Zhu SY; Chen JT
    Med Sci Monit; 2015 Aug; 21():2428-32. PubMed ID: 26286507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced oxidation protein product levels as a marker of oxidative stress in paediatric patients with chronic tonsillitis.
    Ozbay I; Kucur C; Koçak FE; Savran B; Oghan F
    Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):381-385. PubMed ID: 27958598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide and malondialdehyde levels in plasma and tissue of psoriasis patients.
    Sikar Aktürk A; Özdoğan HK; Bayramgürler D; Çekmen MB; Bilen N; Kıran R
    J Eur Acad Dermatol Venereol; 2012 Jul; 26(7):833-7. PubMed ID: 21749467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidative damage parameters in renal tissues of aged and young rats based on gender.
    Uzun D; Korkmaz GG; Sitar ME; Cebe T; Yanar K; Cakatay U; Aydın S
    Clin Interv Aging; 2013; 8():809-15. PubMed ID: 23847413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.